{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:43:07Z","timestamp":1789152187032,"version":"build-2803163510"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.109005","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T02:20:04Z","timestamp":1656382804000},"page":"109005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases"],"prefix":"10.1016","volume":"110","author":[{"given":"Ying-Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Cheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7789-1911","authenticated-orcid":false,"given":"Jian-Hua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109005_b0005","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: A review","volume":"13","author":"Chowdhury","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.intimp.2022.109005_b0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/joim.13372","article-title":"Immunity to SARS-CoV-2 induced by infection or vaccination","volume":"291","author":"Castro","year":"2022","journal-title":"J INTERN MED"},{"key":"10.1016\/j.intimp.2022.109005_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","article-title":"The Intersection of Epigenetics and Metabolism in Trained Immunity","volume":"54","author":"Fanucchi","year":"2021","journal-title":"IMMUNITY"},{"key":"10.1016\/j.intimp.2022.109005_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103361","article-title":"Tryptophan metabolism and immune regulation in the human placenta","volume":"147","author":"Silvano","year":"2021","journal-title":"J REPROD IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"IMMUNITY"},{"key":"10.1016\/j.intimp.2022.109005_b0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"MOL CANCER"},{"key":"10.1016\/j.intimp.2022.109005_b0035","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.18632\/aging.202918","article-title":"Aging and monocyte immunometabolism in COVID-19","volume":"13","author":"Pence","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.intimp.2022.109005_b0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41577-020-0381-7","article-title":"Immunometabolism and HIV-1 pathogenesis: food for thought","volume":"21","author":"S\u00e1ez-Ciri\u00f3n","year":"2021","journal-title":"NAT REV IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"NAT REV RHEUMATOL"},{"key":"10.1016\/j.intimp.2022.109005_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112419","article-title":"Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications","volume":"145","author":"Majidpoor","year":"2022","journal-title":"BIOMED PHARMACOTHER"},{"key":"10.1016\/j.intimp.2022.109005_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005973","article-title":"IL-1\u03b2\/IL-6\/CRP and IL-18\/ferritin: Distinct Inflammatory Programs in Infections","volume":"12","author":"Slaats","year":"2016","journal-title":"PLOS PATHOG"},{"key":"10.1016\/j.intimp.2022.109005_b0060","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.intimp.2022.109005_b0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.celrep.2017.03.043","article-title":"IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling","volume":"19","author":"Timper","year":"2017","journal-title":"CELL REP"},{"key":"10.1016\/j.intimp.2022.109005_b0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00424-019-02332-w","article-title":"Impact of skeletal muscle IL-6 on subcutaneous and visceral adipose tissue metabolism immediately after high- and moderate-intensity exercises","volume":"472","author":"Bertholdt","year":"2020","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.intimp.2022.109005_b0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/blood-2010-06-291245","article-title":"IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin","volume":"117","author":"Botto","year":"2011","journal-title":"BLOOD"},{"key":"10.1016\/j.intimp.2022.109005_b0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00125-008-1019-7","article-title":"IL-6 and metabolism-new evidence and new questions","volume":"51","author":"Krook","year":"2008","journal-title":"DIABETOLOGIA"},{"key":"10.1016\/j.intimp.2022.109005_b0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s42770-021-00663-4","article-title":"CD33 is downregulated by influenza virus H1N1pdm09 and induces ROS and the TNF-\u03b1, IL-1\u03b2, and IL-6 cytokines in human mononuclear cells","volume":"53","author":"Guzm\u00e1n-Beltr\u00e1n","year":"2022","journal-title":"BRAZ J MICROBIOL"},{"key":"10.1016\/j.intimp.2022.109005_b0090","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 Family Cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.intimp.2022.109005_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155577","article-title":"Therapeutic targeting of IL-6 trans-signaling","volume":"144","author":"Rose-John","year":"2021","journal-title":"CYTOKINE"},{"key":"10.1016\/j.intimp.2022.109005_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115327","article-title":"A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors","volume":"28","author":"Kaur","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.intimp.2022.109005_b0105","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4940","article-title":"Interleukin-6 signalling as a valuable cornerstone for molecular medicine (Review)","volume":"47","author":"Trovato","year":"2021","journal-title":"INT J MOL MED"},{"key":"10.1016\/j.intimp.2022.109005_b0110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"IMMUNITY"},{"key":"10.1016\/j.intimp.2022.109005_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/eji.1830180202","article-title":"cDNA cloning of murine interleukin-HP1: homology with human interleukin 6","volume":"18","author":"Van Snick","year":"1988","journal-title":"EUR J IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02879308","article-title":"Three-dimensional structure and function study on the active region in the extracellular ligand-binding domain of human IL-6 receptor","volume":"43","author":"Ren","year":"2000","journal-title":"Sci China C Life Sci"},{"key":"10.1016\/j.intimp.2022.109005_b0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2017.04.036","article-title":"Structural and functional correlates of serum soluble IL-6 receptor level in patients with bipolar disorder","volume":"219","author":"Tu","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/j.intimp.2022.109005_b0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni.3632","article-title":"Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T(H)17 cells","volume":"18","author":"Heink","year":"2017","journal-title":"NAT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0135","article-title":"Classical Signaling and Trans-Signaling Pathways Stimulated by Megalobrama amblycephala IL-6 and IL-6R","volume":"23","author":"Wang","year":"2022","journal-title":"INT J MOL SCI"},{"key":"10.1016\/j.intimp.2022.109005_b0140","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","article-title":"Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms","volume":"53","author":"Kang","year":"2021","journal-title":"EXP MOL MED"},{"key":"10.1016\/j.intimp.2022.109005_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155742","article-title":"Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints","volume":"149","author":"Jarlborg","year":"2022","journal-title":"CYTOKINE"},{"key":"10.1016\/j.intimp.2022.109005_b0150","article-title":"Historical overview of the interleukin-6 family cytokine","volume":"217","author":"Kang","year":"2020","journal-title":"J EXP MED"},{"key":"10.1016\/j.intimp.2022.109005_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155690","article-title":"Blocking only the bad side of IL-6 in inflammation and cancer","volume":"148","author":"Rose-John","year":"2021","journal-title":"CYTOKINE"},{"key":"10.1016\/j.intimp.2022.109005_b0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028456","article-title":"Interleukin (IL-6) Immunotherapy","volume":"10","author":"Tanaka","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.intimp.2022.109005_b0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"INT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-94-024-0921-5_4","article-title":"Regulation of IL-6 in Immunity and Diseases","volume":"941","author":"Tanaka","year":"2016","journal-title":"ADV EXP MED BIOL"},{"key":"10.1016\/j.intimp.2022.109005_b0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: A Masterplayer in the Cytokine Network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"key":"10.1016\/j.intimp.2022.109005_b0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.intimp.2022.109005_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155238","article-title":"Interleukin-6 in Rheumatoid Arthritis","volume":"21","author":"Pandolfi","year":"2020","journal-title":"INT J MOL SCI"},{"key":"10.1016\/j.intimp.2022.109005_b0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2018.09.002","article-title":"IL-6: a cytokine at the crossroads of autoimmunity","volume":"55","author":"Jones","year":"2018","journal-title":"CURR OPIN IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-immunol-101220-023458","article-title":"IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19","volume":"40","author":"Kishimoto","year":"2022","journal-title":"ANNU REV IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104402","article-title":"Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab","volume":"149","author":"Atzeni","year":"2019","journal-title":"PHARMACOL RES"},{"key":"10.1016\/j.intimp.2022.109005_b0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy","volume":"75","author":"McConnell","year":"2021","journal-title":"J HEPATOL"},{"key":"10.1016\/j.intimp.2022.109005_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"CELL IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"NAT REV CLIN ONCOL"},{"key":"10.1016\/j.intimp.2022.109005_b0220","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.intimp.2022.109005_b0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in Cancer Immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"MOL CANCER"},{"key":"10.1016\/j.intimp.2022.109005_b0230","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1038\/s41467-020-18701-4","article-title":"Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency","volume":"11","author":"Werner-Klein","year":"2020","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.intimp.2022.109005_b0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"NAT REV IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1084\/jem.169.1.333","article-title":"The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome","volume":"169","author":"Waage","year":"1989","journal-title":"J EXP MED"},{"key":"10.1016\/j.intimp.2022.109005_b0245","article-title":"CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives","volume":"13","author":"Mortezaee","year":"2022","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0250","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ajcn\/nqy052","article-title":"A comparison of methods for adjusting biomarkers of iron, zinc, and selenium status for the effect of inflammation in an older population: a case for interleukin 6","volume":"107","author":"MacDonell","year":"2018","journal-title":"AM J CLIN NUTR"},{"key":"10.1016\/j.intimp.2022.109005_b0255","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"NAT REV DRUG DISCOV"},{"key":"10.1016\/j.intimp.2022.109005_b0260","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2022.109005_b0265","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.intimp.2022.109005_b0270","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00281-019-00747-2","article-title":"The role of interleukin-6 in glucose homeostasis and lipid metabolism","volume":"41","author":"Lehrskov","year":"2019","journal-title":"SEMIN IMMUNOPATHOL"},{"key":"10.1016\/j.intimp.2022.109005_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2021.104188","article-title":"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)","volume":"137","author":"Norooznezhad","year":"2021","journal-title":"MICROVASC RES"},{"key":"10.1016\/j.intimp.2022.109005_b0280","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","article-title":"New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology","volume":"18","author":"Giraldez","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2022.109005_b0285","doi-asserted-by":"crossref","first-page":"R626","DOI":"10.1152\/ajpregu.00373.2016","article-title":"Lack of skeletal muscle IL-6 influences hepatic glucose metabolism in mice during prolonged exercise","volume":"312","author":"Bertholdt","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.intimp.2022.109005_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110389","article-title":"IL-6-induced FOXO1 activity determines the dynamics of metabolism in CD8 T cells cross-primed by liver sinusoidal endothelial cells","volume":"38","author":"Dudek","year":"2022","journal-title":"CELL REP"},{"key":"10.1016\/j.intimp.2022.109005_b0295","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2334\/josnusd.20-0010","article-title":"Glucose transporter 4 mediates LPS-induced IL-6 production in osteoblasts under high glucose conditions","volume":"62","author":"Kato","year":"2020","journal-title":"J ORAL SCI"},{"key":"10.1016\/j.intimp.2022.109005_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173675","article-title":"Role of muscle IL-6 in gender-specific metabolism in mice","volume":"12","author":"Molinero","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.intimp.2022.109005_b0305","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/hep.29089","article-title":"The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism","volume":"66","author":"von Loeffelholz","year":"2017","journal-title":"HEPATOLOGY"},{"key":"10.1016\/j.intimp.2022.109005_b0310","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s42255-022-00538-4","article-title":"Interleukin 6 as an energy allocator in muscle tissue","volume":"4","author":"Kistner","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.intimp.2022.109005_b0315","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.intimp.2022.109005_b0320","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1111\/febs.15863","article-title":"AMPK, metabolism, and vascular function","volume":"288","author":"Rodr\u00edguez","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.intimp.2022.109005_b0325","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.celrep.2019.02.044","article-title":"Parabrachial Interleukin-6 Reduces Body Weight and Food Intake and Increases Thermogenesis to Regulate Energy Metabolism","volume":"26","author":"Mishra","year":"2019","journal-title":"CELL REP"},{"key":"10.1016\/j.intimp.2022.109005_b0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092474","article-title":"IL-6: A Potential Role in Cardiac Metabolic Homeostasis","volume":"19","author":"Xu","year":"2018","journal-title":"INT J MOL SCI"},{"key":"10.1016\/j.intimp.2022.109005_b0335","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2169\/internalmedicine.5244-20","article-title":"Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19","volume":"59","author":"Nakamura","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.intimp.2022.109005_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010024","article-title":"Obesity-Induced TNF\u03b1 and IL-6 Signaling: The Missing Link between Obesity and Inflammation-Driven Liver and Colorectal Cancers","volume":"11","author":"Kern","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2022.109005_b0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"IMMUNITY"},{"key":"10.1016\/j.intimp.2022.109005_b0350","first-page":"504","article-title":"Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity","volume":"11","author":"Henning","year":"2021","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.intimp.2022.109005_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010175","article-title":"Puerarin Attenuates Obesity-Induced Inflammation and Dyslipidemia by Regulating Macrophages and TNF-Alpha in Obese Mice","volume":"10","author":"Noh","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2022.109005_b0360","article-title":"Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm","volume":"12","author":"Liu","year":"2021","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0365","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/eji.202049159","article-title":"Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein","volume":"51","author":"Palasiewicz","year":"2021","journal-title":"EUR J IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0370","first-page":"1026","article-title":"Immunometabolic bases of type 2 diabetes in the severity of COVID-19, World","volume":"12","author":"Viurcos-Sanabria","year":"2021","journal-title":"J Diabetes"},{"key":"10.1016\/j.intimp.2022.109005_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.732913","article-title":"Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19","volume":"12","author":"Khwatenge","year":"2021","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0380","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41467-021-21907-9","article-title":"Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications","volume":"12","author":"Xiao","year":"2021","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.intimp.2022.109005_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109479","article-title":"Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication","volume":"36","author":"Williams","year":"2021","journal-title":"CELL REP"},{"key":"10.1016\/j.intimp.2022.109005_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104090","article-title":"Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV","volume":"81","author":"Calvet-Mirabent","year":"2022","journal-title":"EBIOMEDICINE"},{"key":"10.1016\/j.intimp.2022.109005_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222112020","article-title":"A Critical Review of the Biochemical Mechanisms and Epigenetic Modifications in HIV- and Antiretroviral-Induced Metabolic Syndrome","volume":"22","author":"Mohan","year":"2021","journal-title":"INT J MOL SCI"},{"key":"10.1016\/j.intimp.2022.109005_b0400","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pharma.2021.01.005","article-title":"Metabolic syndrome among people with HIV in central Tunisia: Prevalence and associated factors","volume":"79","author":"Aouam","year":"2021","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.intimp.2022.109005_b0405","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s13365-021-01005-8","article-title":"Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected","volume":"27","author":"Shiau","year":"2021","journal-title":"J NEUROVIROL"},{"key":"10.1016\/j.intimp.2022.109005_b0410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/QAI.0000000000002841","article-title":"Associations Between Central Obesity and Lifelong Antiviral Therapy in Adults Living With HIV Acquired From Early Childhood","volume":"89","author":"Sahagun","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.intimp.2022.109005_b0415","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1873-3468.14220","article-title":"Local and systemic effects of interleukin-6 (IL-6) in inflammation and cancer","volume":"596","author":"Rose-John","year":"2022","journal-title":"FEBS LETT"},{"key":"10.1016\/j.intimp.2022.109005_b0420","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jmv.26398","article-title":"A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19)","volume":"93","author":"Cui","year":"2021","journal-title":"J MED VIROL"},{"key":"10.1016\/j.intimp.2022.109005_b0425","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202006-2405OC","article-title":"Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation","volume":"203","author":"Lim","year":"2021","journal-title":"A Meta-analysis, Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2022.109005_b0430","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/1744666X.2021.1919086","article-title":"The role of IL-6 and IL-6 blockade in COVID-19","volume":"17","author":"Potere","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.intimp.2022.109005_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J AUTOIMMUN"},{"key":"10.1016\/j.intimp.2022.109005_b0440","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12967-020-02339-3","article-title":"Why tocilizumab could be an effective treatment for severe COVID-19?","volume":"18","author":"Fu","year":"2020","journal-title":"J TRANSL MED"},{"key":"10.1016\/j.intimp.2022.109005_b0445","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis","volume":"326","author":"Shankar-Hari","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2022.109005_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J CLIN VIROL"},{"key":"10.1016\/j.intimp.2022.109005_b0455","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/bib\/bbaa259","article-title":"Computer-aided prediction and design of IL-6 inducing peptides: IL-6 plays a crucial role in COVID-19","volume":"22","author":"Dhall","year":"2021","journal-title":"BRIEF BIOINFORM"},{"key":"10.1016\/j.intimp.2022.109005_b0460","article-title":"The Value of Interleukin-6 among Several Inflammatory Markers as a Predictor of Respiratory Failure in COVID-19 Patients","volume":"11","author":"Fujino","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.intimp.2022.109005_b0465","first-page":"223","article-title":"IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?","volume":"34","author":"Atal","year":"2020","journal-title":"Pharmaceut Med"},{"key":"10.1016\/j.intimp.2022.109005_b0470","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2021.11121","article-title":"IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?","volume":"326","author":"Matthay","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2022.109005_b0475","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2022.109005_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.619906","article-title":"sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection","volume":"12","author":"Jagtap","year":"2021","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0485","doi-asserted-by":"crossref","first-page":"5545181","DOI":"10.1155\/2021\/5545181","article-title":"Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF","volume":"2021","author":"Wu","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2022.109005_b0490","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000488614","article-title":"HBV Facilitated Hepatocellular Carcinoma Cells Proliferation by Up-Regulating Angiogenin Expression Through IL-6","volume":"46","author":"Zhou","year":"2018","journal-title":"CELL PHYSIOL BIOCHEM"},{"key":"10.1016\/j.intimp.2022.109005_b0495","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1159\/000484390","article-title":"IL-17 Activates the IL-6\/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma","volume":"43","author":"Hu","year":"2017","journal-title":"CELL PHYSIOL BIOCHEM"},{"key":"10.1016\/j.intimp.2022.109005_b0500","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.760971","article-title":"IL-6\/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"FRONT ONCOL"},{"key":"10.1016\/j.intimp.2022.109005_b0505","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1002\/jcb.27259","article-title":"IL-6\/STAT3 pathway intermediates M1\/M2 macrophage polarization during the development of hepatocellular carcinoma","volume":"119","author":"Yin","year":"2018","journal-title":"J CELL BIOCHEM"},{"key":"10.1016\/j.intimp.2022.109005_b0510","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.hbpd.2018.08.009","article-title":"IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6\/STAT3 signaling","volume":"17","author":"Pu","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.intimp.2022.109005_b0515","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.813897","article-title":"(Im)maturity in Tumor Ecosystem","volume":"11","author":"Mortezaee","year":"2022","journal-title":"FRONT ONCOL"},{"key":"10.1016\/j.intimp.2022.109005_b0520","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2017.02.128","article-title":"IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model","volume":"486","author":"Liu","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2022.109005_b0525","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.4659","article-title":"Checkpoint inhibitor\/interleukin-based combination therapy of cancer","author":"Mortezaee","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.intimp.2022.109005_b0530","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-022-00667-8","article-title":"Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy","author":"Mortezaee","year":"2022","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.intimp.2022.109005_b0535","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2014.08.039","article-title":"Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells","volume":"147","author":"Wan","year":"2014","journal-title":"GASTROENTEROLOGY"},{"key":"10.1016\/j.intimp.2022.109005_b0540","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7150\/thno.51777","article-title":"Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages","volume":"11","author":"Chen","year":"2021","journal-title":"THERANOSTICS"},{"key":"10.1016\/j.intimp.2022.109005_b0545","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/QAD.0000000000000155","article-title":"Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression","volume":"28","author":"Hamlyn","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.intimp.2022.109005_b0550","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/1570162X18666200712174642","article-title":"The Effect of Antiretroviral Therapy on IL-6, IL-1\u03b2, TNF-\u03b1, IFN-\u03b3 Levels and their Relationship with HIV-RNA and CD4+ T Cells in HIV Patients","volume":"18","author":"Okay","year":"2020","journal-title":"CURR HIV RES"},{"key":"10.1016\/j.intimp.2022.109005_b0555","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.molcel.2018.05.007","article-title":"Vpr Targets TET2 for Degradation by CRL4(VprBP) E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication","volume":"70","author":"Lv","year":"2018","journal-title":"MOL CELL"},{"key":"10.1016\/j.intimp.2022.109005_b0560","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/jiv123","article-title":"Factors Associated With Plasma IL-6 Levels During HIV Infection","volume":"212","author":"Borges","year":"2015","journal-title":"J INFECT DIS"},{"key":"10.1016\/j.intimp.2022.109005_b0565","doi-asserted-by":"crossref","first-page":"19482","DOI":"10.7448\/IAS.17.4.19482","article-title":"Determinants of IL-6 levels during HIV infection","volume":"17","author":"Borges","year":"2014","journal-title":"J INT AIDS SOC"},{"key":"10.1016\/j.intimp.2022.109005_b0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133494","article-title":"Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation","volume":"10","author":"Sindhu","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.intimp.2022.109005_b0575","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/QAI.0000000000001444","article-title":"HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer","volume":"75","author":"Taylor","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.intimp.2022.109005_b0580","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1089\/aid.2012.0309","article-title":"Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial","volume":"29","author":"McDonald","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.intimp.2022.109005_b0585","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biochi.2021.07.001","article-title":"HIV-1 Tat: An update on transcriptional and non-transcriptional functions","volume":"190","author":"Ali","year":"2021","journal-title":"BIOCHIMIE"},{"key":"10.1016\/j.intimp.2022.109005_b0590","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-014-0214-3","article-title":"Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes","volume":"11","author":"Nookala","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.intimp.2022.109005_b0595","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.atherosclerosis.2007.04.008","article-title":"HIV protease inhibitors increase TNF-alpha and IL-6 expression in macrophages: involvement of the RNA-binding protein HuR","volume":"195","author":"Zhou","year":"2007","journal-title":"ATHEROSCLEROSIS"},{"key":"10.1016\/j.intimp.2022.109005_b0600","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humimm.2019.11.007","article-title":"Association of IL-6, IL-10 and CXCL10 serum concentrations with visceral Kaposi's sarcoma in people living with HIV\/AIDS","volume":"81","author":"Lopes","year":"2020","journal-title":"HUM IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0605","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001634","article-title":"The emerging role of perivascular cells (pericytes) in viral pathogenesis","volume":"102","author":"Butsabong","year":"2021","journal-title":"J GEN VIROL"},{"key":"10.1016\/j.intimp.2022.109005_b0610","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9061137","article-title":"Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells","volume":"9","author":"Yaiw","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.intimp.2022.109005_b0615","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1155\/2012\/987476","article-title":"Supra-additive expression of interleukin-6, interleukin-8 and basic fibroblast growth factor in vascular smooth muscle cells following coinfection with Chlamydia pneumoniae and cytomegalovirus as a novel link between infection and atherosclerosis","volume":"23","author":"Prochnau","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.intimp.2022.109005_b0620","doi-asserted-by":"crossref","first-page":"18084","DOI":"10.1038\/s41598-021-97522-x","article-title":"Macrophage-derived interleukin-6 is necessary and sufficient for choroidal angiogenesis","volume":"11","author":"Droho","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2022.109005_b0625","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1099\/vir.0.025395-0","article-title":"Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor","volume":"92","author":"Fiorentini","year":"2011","journal-title":"J GEN VIROL"},{"key":"10.1016\/j.intimp.2022.109005_b0630","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001180","article-title":"HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis","volume":"3","author":"Slinger","year":"2010","journal-title":"SCI SIGNAL"},{"key":"10.1016\/j.intimp.2022.109005_b0635","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12974-014-0219-y","article-title":"Retinal pericytes and cytomegalovirus infectivity: implications for HCMV-induced retinopathy and congenital ocular disease","volume":"12","author":"Wilkerson","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.intimp.2022.109005_b0640","article-title":"Human cytomegalovirus infection and its association with gestational diabetes mellitus during pregnancy","volume":"10","author":"Wang","year":"2022","journal-title":"PEERJ"},{"key":"10.1016\/j.intimp.2022.109005_b0645","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-virology-092818-015550","article-title":"Adenovirus Entry: From Infection to Immunity","volume":"6","author":"Greber","year":"2019","journal-title":"ANNU REV VIROL"},{"key":"10.1016\/j.intimp.2022.109005_b0650","first-page":"410","article-title":"Adenovirus Vector-Induced IL-6 Promotes Leaky Adenoviral Gene Expression","volume":"206","author":"Shimizu","year":"2021","journal-title":"Leading to Acute Hepatotoxicity, J IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0655","first-page":"14","article-title":"Analysis of the clinical features and the risk factors of severe adenovirus pneumonia in children","volume":"59","author":"Huang","year":"2021","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.intimp.2022.109005_b0660","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.21037\/apm-21-675","article-title":"Establishment of a predictive nomogram and its validation for severe adenovirus pneumonia in children","volume":"10","author":"Shen","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.intimp.2022.109005_b0665","doi-asserted-by":"crossref","DOI":"10.3390\/ph14101046","article-title":"Corylin Ameliorates LPS-Induced Acute Lung Injury via Suppressing the MAPKs and IL-6\/STAT3 Signaling Pathways","volume":"14","author":"Chen","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.intimp.2022.109005_b0670","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.intimp.2022.109005_b0675","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.21037\/jtd-19-4067","article-title":"Comparison of clinical characteristics and inflammatory cytokines between hypoxemic and non-hypoxemic human adenovirus 55 pneumonia","volume":"12","author":"Lim","year":"2020","journal-title":"J THORAC DIS"},{"key":"10.1016\/j.intimp.2022.109005_b0680","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/infdis\/jiaa524","article-title":"Clinical Features, Replication Competence, and Innate Immune Responses of Human Adenovirus Type 7 Infection","volume":"223","author":"Chen","year":"2021","journal-title":"J INFECT DIS"},{"key":"10.1016\/j.intimp.2022.109005_b0685","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.551413","article-title":"Adenovirus 7 Induces Interlukin-6 Expression in Human Airway Epithelial Cells via p38\/NF-\u03baB Signaling Pathway","volume":"11","author":"Qi","year":"2020","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0690","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061837","article-title":"Foxtail Millet Improves Blood Glucose Metabolism in Diabetic Rats through PI3K\/AKT and NF-\u03baB Signaling Pathways Mediated by Gut Microbiota","volume":"13","author":"Ren","year":"2021","journal-title":"NUTRIENTS"},{"key":"10.1016\/j.intimp.2022.109005_b0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: At the Borders of Autoimmunity and Inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0700","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s13287-021-02560-x","article-title":"Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-\u03baB signaling and glycolysis","volume":"12","author":"Pan","year":"2021","journal-title":"STEM CELL RES THER"},{"key":"10.1016\/j.intimp.2022.109005_b0705","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.micpath.2017.04.034","article-title":"Evaluation of Adenovirus-36 (Ad-36) antibody seropositivity and adipokine levels in obese children","volume":"108","author":"Kocazeybek","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.intimp.2022.109005_b0710","series-title":"Does enterovirus 71 urge for effective vaccine control strategies?","first-page":"e2322","author":"Swain","year":"2022"},{"key":"10.1016\/j.intimp.2022.109005_b0715","article-title":"Enterovirus 71 Antagonizes Antiviral Effects of Type III Interferon and Evades the Clearance of Intestinal Intraepithelial Lymphocytes","volume":"12","author":"Dong","year":"2021","journal-title":"FRONT MICROBIOL"},{"key":"10.1016\/j.intimp.2022.109005_b0720","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700903","article-title":"Clinical and Immune Responses of Peripheral Chemical Sympathectomy in Enterovirus 71 Infection","volume":"12","author":"Liao","year":"2021","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.intimp.2022.109005_b0725","first-page":"2718","article-title":"IL-6, IL-10 and IL-13 are associated with pathogenesis in children with Enterovirus 71 infection","volume":"7","author":"Chen","year":"2014","journal-title":"INT J CLIN EXP MED"},{"key":"10.1016\/j.intimp.2022.109005_b0730","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4149\/av_2020_311","article-title":"Elevated circulating miR-494 in plasma of children with enterovirus 71 induced hand, foot, and mouth disease and its potential diagnostic value","volume":"64","author":"Liu","year":"2020","journal-title":"ACTA VIROL"},{"key":"10.1016\/j.intimp.2022.109005_b0735","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12879-015-0965-1","article-title":"Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections","volume":"15","author":"Ye","year":"2015","journal-title":"BMC INFECT DIS"},{"key":"10.1016\/j.intimp.2022.109005_b0740","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/00325481.2018.1416257","article-title":"Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease","volume":"130","author":"Lee","year":"2018","journal-title":"POSTGRAD MED"},{"key":"10.1016\/j.intimp.2022.109005_b0745","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.micpath.2019.03.028","article-title":"Autophagy induced by enterovirus 71 regulates the production of IL-6 through the p38MAPK and ERK signaling pathways","volume":"131","author":"Cao","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.intimp.2022.109005_b0750","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/kjm2.12299","article-title":"Autophagy and metabolism","volume":"37","author":"Lin","year":"2021","journal-title":"KAOHSIUNG J MED SCI"},{"key":"10.1016\/j.intimp.2022.109005_b0755","first-page":"778","article-title":"Autophagy Regulates Stress Responses, Metabolism, and Anticancer Immunity, Trends","volume":"7","author":"White","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2022.109005_b0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008142","article-title":"EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production","volume":"15","author":"Luo","year":"2019","journal-title":"PLOS PATHOG"},{"key":"10.1016\/j.intimp.2022.109005_b0765","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/d41586-020-00641-0","article-title":"Ghostly metabolic messages from dying cells","volume":"580","author":"Green","year":"2020","journal-title":"NATURE"},{"key":"10.1016\/j.intimp.2022.109005_b0770","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1139\/cjm-2020-0572","article-title":"Dengue virus: epidemiology, biology, and disease aetiology","volume":"67","author":"Roy","year":"2021","journal-title":"CAN J MICROBIOL"},{"key":"10.1016\/j.intimp.2022.109005_b0775","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26226768","article-title":"Updates on Dengue Vaccine and Antiviral: Where Are We Heading?","volume":"26","author":"Norshidah","year":"2021","journal-title":"MOLECULES"},{"key":"10.1016\/j.intimp.2022.109005_b0780","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2015.10.005","article-title":"Inhibition of dengue virus production and cytokine\/chemokine expression by ribavirin and compound A","volume":"124","author":"Rattanaburee","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.intimp.2022.109005_b0785","first-page":"202","article-title":"Role of TNF \u03b1, IL-6 and CXCL10 in Dengue disease severity, Iran","volume":"10","author":"Masood","year":"2018","journal-title":"J Microbiol"},{"key":"10.1016\/j.intimp.2022.109005_b0790","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4269\/ajtmh.2000.63.71","article-title":"Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production","volume":"63","author":"Huang","year":"2000","journal-title":"AM J TROP MED HYG"},{"key":"10.1016\/j.intimp.2022.109005_b0795","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virusres.2007.03.003","article-title":"Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES","volume":"126","author":"Lee","year":"2007","journal-title":"VIRUS RES"},{"key":"10.1016\/j.intimp.2022.109005_b0800","article-title":"Different Profiles of Cytokines, Chemokines and Coagulation Mediators Associated with Severity in Brazilian Patients Infected with Dengue Virus","volume":"13","author":"Fiestas","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2022.109005_b0805","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/VHRM.S280962","article-title":"D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review","volume":"16","author":"Eljilany","year":"2020","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.intimp.2022.109005_b0810","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.hest.2020.11.001","article-title":"COVID-19 and stroke: A review","volume":"2","author":"Qi","year":"2021","journal-title":"Brain Hemorrhages"},{"key":"10.1016\/j.intimp.2022.109005_b0815","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1111\/cas.15106","article-title":"Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer","volume":"112","author":"Kobayashi","year":"2021","journal-title":"CANCER SCI"},{"key":"10.1016\/j.intimp.2022.109005_b0820","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"BLOOD"},{"key":"10.1016\/j.intimp.2022.109005_b0825","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/03009734.2019.1645248","article-title":"Adipocytes express tissue factor and FVII and are procoagulant in a TF\/FVIIa-dependent manner","volume":"124","author":"Ed\u00e9n","year":"2019","journal-title":"Ups J Med Sci"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922004891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922004891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:57:29Z","timestamp":1761587849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922004891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":165,"alternative-id":["S1567576922004891"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109005"}}